Cell and Gene Therapy Regulatory Affairs Summit
Evvnt Promotion / evvnt
Archivio
28.10.2024 - 30.10.2024 Washington Marriott Capitol Hill, 175 L Street Northeast, 20002 Washington, District of Columbia, USA
Time: 8:00 AM - 3:30 PM
Temi della conferenza
The Ultimate Chance to Tackle Regulatory Challenges in the Cell and Gene Therapy Space!
With over 5,000 cell and gene therapies in pre-clinical and clinical development worldwide, regulatory clarity is crucial for developers striving for efficient and seamless approvals in their first regulatory submissions. Leading innovators are pioneering new approaches, like in vivo gene editing, rapidly pushing products from the clinic to commercialization.
The Ultimate Chance to Tackle Regulatory Challenges in the Cell and Gene Therapy Space!
With over 5,000 cell and gene therapies in pre-clinical and clinical development worldwide, regulatory clarity is crucial for developers striving for efficient and seamless approvals in their first regulatory submissions. Leading innovators are pioneering new approaches, like in vivo gene editing, rapidly pushing products from the clinic to commercialization.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2504368-3?pid=3507
Speakers: Annelise Brossel | Director, Regulatory Affairs and Quality Assurance | Vivet Therapeutics, and more
URL:
Brochure: https://go.evvnt.com/2504368-3?pid=3507
Speakers: Annelise Brossel | Director, Regulatory Affairs and Quality Assurance | Vivet Therapeutics, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2504368-1?pid=3507
Ms. Kelly Cassidy
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
